Will Pacific Biosciences of California Inc (PACB) Underperform the Rest of the Stocks in the Healthcare Sector? – InvestorsObserver

A rating of 43 puts Pacific Biosciences of California Inc (PACB) near the top of the Healthcare sector according to InvestorsObserver. Pacific Biosciences of California Inc’s score of 43 means that it ranks higher than 43% of stocks in the sector. In addition, its overall score of 37 ranks it higher than 37% of all stocks.

Overall Score - 37
PACB has an Overall Score of 37. Find out what this means to you and get the rest of the rankings on PACB!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What’s Happening With Pacific Biosciences of California Inc Stock Today?

Pacific Biosciences of California Inc (PACB) stock is trading at $11.25 as of 12:24 PM on Tuesday, Nov 15, an increase of $1.12, or 11.06% from the previous closing price of $10.13. The stock has traded between $11.04 and $12.37 so far today. Volume today is 5,024,526 compared to average volume of 6,356,010. Click Here to get the full Stock Report for Pacific Biosciences of California Inc stock.
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You’re all set to receive the Morning Update newsletter
Stock Price data may be delayed up to 15 minutes.
Copyright © 2022. Portions of this content may be copyrighted by Fresh Brewed Media, Investors Observer, and/or O2 Media LLC. All Rights Reserved. Portions of this content protected by US Patent numbers 7,865,496, 7,856,390, and 7,716,116. Investing in stocks, bonds, option and other financial instruments involve risks and may not be suitable for everyone. Portfolio results are unaudited and based on varying investment expiration dates. Terms of Service | Privacy Policy


Leave a Comment

Ads Blocker Image Powered by Code Help Pro

Ads Blocker Detected!!!

Welcome to FactsPrime

Sorry, We have detected that you have activated Ad-Blocker. Please Consider supporting us by disabling your Ad Blocker, It helps us in maintaining this website. To View the content, Please disable adblocker and refresh the page.

Thank You !!!